NUTRA PHARMA CORP. Deferred Revenue
NUTRA PHARMA CORP. (NPHC) had Deferred Revenue of $234.76 thousand as of 2024-12-31, per its 10-K filed 2026-05-20.
Financial Statements › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2026-05-20
- 2024-12-31: Deferred Revenue $234.76K.
| Period end | Deferred Revenue |
|---|---|
| 2024-12-31 | $234.76K 10-K · filed 2026-05-20 |